- Report
- May 2023
- 98 Pages
Global
From €3500EUR$4,251USD£3,124GBP
- Report
- May 2023
- 100 Pages
Global
From €3500EUR$4,251USD£3,124GBP
- Report
- September 2025
Global
From €3087EUR$3,500USD£2,662GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1323EUR$1,500USD£1,141GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €3969EUR$4,500USD£3,422GBP
- Report
- October 2024
Global
From €3087EUR$3,500USD£2,662GBP
The Herpes Test market within the In Vitro Diagnostics (IVD) industry is a segment of the larger IVD market that focuses on the diagnosis of herpes simplex virus (HSV) infections. Herpes tests are used to detect the presence of HSV in a patient's sample, such as a swab from the affected area or a blood sample. The tests are used to diagnose HSV infections, as well as to monitor the effectiveness of treatment. Herpes tests are available in a variety of formats, including rapid tests, ELISA tests, and PCR tests.
Some of the companies in the Herpes Test market include Abbott, Becton Dickinson, Bio-Rad, Cepheid, DiaSorin, Hologic, Roche, and Siemens Healthineers. Show Less Read more